Home
Sharon Mates, Chairman and CEO: Intra-Cellular Therapies ITCI Sell · Filed 24/08/23
Trade details
- Type
- Insider sale
- Amount
- $3,327,703.6
- Shares · price
- 44,134 sh · $75.40 a share
- Held after
- 1,079,208 sh
- Trade date
- 24/08/21
- Filed
- 24/08/23
- Days to filing
- 2 days
Sold 3.9% of holdings
- Share of holding sold
- 3.9%
Intra-Cellular Therapies trades, last 26 weeks
What else happened in Intra-Cellular Therapies around then
Filed or reported within 30 days of the trade day · 24/07/22~24/09/20Sharon Mates's recent trades
- Sharon Mates
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 planIntra-Cellular Therapies
ITCI
$4.2M
50,163 sh
$4.2M
Filed 24/12/06
Traded 24/12/05
- Sharon Mates
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 planIntra-Cellular Therapies
ITCI
$2.4M
27,667 sh
$2.4M
Filed 24/12/06
Traded 24/12/04
- Sharon Mates
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 planIntra-Cellular Therapies
ITCI
$2M
23,333 sh
$2M
Filed 24/12/06
Traded 24/12/04
- Sharon Mates
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 planIntra-Cellular Therapies
ITCI
$129.9K
1,534 sh
$129.9K
Filed 24/12/06
Traded 24/12/05
- Sharon Mates
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 planIntra-Cellular Therapies
ITCI
$2.2M
29,832 sh
$2.2M
Filed 24/08/30
Traded 24/08/29